Cargando…
Targeted nanoparticle-mediated LHPP for melanoma treatment
Background: Phospholysine phosphohistidine inorganic pyrophosphate phosphatase (LHPP) is a novel tumor suppressor. However, whether LHPP is effective to melanoma has not been investigated. Gene therapy provides a new strategy for the treatment of melanoma. Currently, it suffers from the lack of safe...
Autores principales: | Zhang, Qianqian, Xiong, Meimei, Liu, Jinlu, Wang, Shuai, Du, Ting, Kang, Tianyi, Liu, Yu, Cheng, Hao, Huang, Meijuan, Gou, Maling |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6516749/ https://www.ncbi.nlm.nih.gov/pubmed/31190803 http://dx.doi.org/10.2147/IJN.S196374 |
Ejemplares similares
-
Targeted Nanotherapeutics Using LACTB Gene Therapy Against Melanoma
por: Liu, Jinlu, et al.
Publicado: (2021) -
A biomimetic nanoparticle-enabled toxoid vaccine against melittin
por: Kang, Tianyi, et al.
Publicado: (2018) -
LHPP Inhibits the Proliferation and Metastasis of Renal Cell Carcinoma
por: Zhang, Xiaoting, et al.
Publicado: (2020) -
A Vesicular Stomatitis Virus‐Inspired DNA Nanocomplex for Ovarian Cancer Therapy
por: Zhao, Wei, et al.
Publicado: (2017) -
LHPP-Mediated Histidine Dephosphorylation Suppresses the Self-Renewal of Mouse Embryonic Stem Cells
por: Xia, Rong Mu, et al.
Publicado: (2021)